Table 3: Variables related to outcomes in patients who tested positive with COVID-19.
|
Death |
Ongoing hospitalization |
Hospital discharge |
# of patients |
24 |
17 |
31 |
Average age |
73 |
72 |
62 |
Gender Male |
13/24 (54%) |
10/17 (59%) |
15/31 (48%) |
Average D dimer (ug/mL FEU) |
13.8 |
17.4 |
5.6 |
Diabetes |
13/24 (54%) |
13/17 (76%) |
13/31 (42%) |
Hypertension |
21/24 (88%) |
14/17 (82%) |
20/31 (65%) |
Average Troponin (ng/L) |
179 |
431 |
29 |
Average creatinine (mg/dl) |
3.9 |
3.4 |
1.2 |
Consolidation |
20/20 (100%) |
17/17 (100%) |
28/31 (90%) |
Intubated |
14/24 (58%) |
15/17 (88%) |
2/31 (6%) |
Full dose heparin |
10/24 (42%) |
8/17 (47%) |
0/31 (0%) |
Subcutaneous heparin |
2/24 (8%) |
5/17 (29%) |
5/31 (16%) |
Enoxaparin |
9/24 (38%) |
4/17 (24%) |
23/31 (74%) |
Hydroxychloroquine |
20/24 (83%) |
13/17 (76%) |
19/31 (61%) |